In vitro absorption of triethanolamine through human skin

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 22, Issue 3, 2003, Pages 137-145

  Kraeling, Margaret E K ^a   Bronaugh, Robert L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Human skin; In vitro; Skin absorption; TEA; Triethanolamine

Indexed keywords

COSMETIC; OIL; TRIETHANOLAMINE; WATER;

ARTICLE; DIFFUSION; DRUG FORMULATION; EMULSION; EXPOSURE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IONIZATION; LIQUID; PH; SIMULATION; SKIN ABSORPTION; SKIN PENETRATION;

EID: 0041562490     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.1081/CUS-120022754     Document Type: Article

References (12)

1. Furches BJ. Alkanolamines in creams and lotions. Cosmet Toiletries 1980; 95:63-66.
2. Cosmetic Ingredient Review. Final report on the safety assessment of triethanolamine, diethanolamine, and monoethanolamine. J Am Coll Toxicol 1983; 7:183-235.
3. Melnick RL, Tomaszewski KE. Triethanolamine. In: Buhler DR, Reed DJ, eds. Ethyl Browning's Toxicity and Metabolism of Industrial Solvents. 2nd ed. Vol 2: Nitrogen and phosphorous solvents. New York: Elsevier Science Publishers, 1990.
4. National Toxicology Program Technical Report, TR-449, Toxicology and Carcinogenesis Studies of Triethanolamine in F344 Rats and B6C3F1 Mice. NIH Pub. No. 00-3365; 1999.
5. Stott WT, Waechter JM Jr, Rick DL, Mendrala AL. Absorption, distribution, metabolism and excretion of intravenously and dermally administered triethanolamine in mice. Fd Chem Toxicol 2000; 38:1043-1051.
6. Bronaugh RL, Hood HL, Kraeling MEK, Yourick JJ. Determination of percutaneous absorption by in vitro techniques. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methodology. New York: Marcel Dekker, Inc., 1999.
7. Kraeling MEK, Bronaugh RL. In vitro percutaneous absorption of alpha hydroxy acids in human skin. J Soc Cosmet Chem 1997; 48:187-197.
8. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies IV: the flow-through diffusion cell. J Pharm Sci 1985; 74:64-67.
9. Collier SW, Sheikh NM, Sakr A, Stewart RF, Bronaugh RL. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Toxicol Appl Pharmacol 1989; 99:522-533.
10. Bronaugh RL, Stewart RF, Simon M. Methods for in vitro percutaneous absorption studies VII: use of excised human skin. J Pharm Sci 1986; 75:1094-1097.
11. 14C-Salicylate in human and canine knee joints. J Clin Pharmacol 1982; 22:42-48.
12. Kraeling ME, Jung CT, Yourick JJ, Bronaugh RL. In vitro percutaneous absorption of diethanolamine (DEA) in human skin. Toxicologist 2002; 66(1), Abstract No. 807.